Chat with us
Aventon Pharma: Global CDMO Services

Committed to Quality, Empowering Global Pharma with Innovation and Excellence

Pharma CDMO

At Aventon Pharma Solutions Pvt. Ltd., we uphold the highest standards of quality in every aspect of pharmaceutical research, development, and manufacturing. Our unwavering commitment to innovation, regulatory compliance, and cost-effective solutions ensures that we deliver world-class pharmaceutical formulations to meet the evolving needs of global healthcare.

  • 75+ years of expertise in complex dosage forms and innovative formulations.

  • Trusted global healthcare partner delivering safe and effective medicines.

Innovative Solutions, Trusted Services, Global Impact

Our Services

Formulation

Formulation Technology Platform

Our advanced Formulation Technology Platform is designed to develop innovative and complex pharmaceutical dosage forms.

+ Read More
Formulation

Analytical Development

We offer comprehensive analytical development services to support drug formulation, stability studies, and regulatory submissions.

+ Read More
Formulation

Regulatory and Data Analysis Platform

Our Regulatory and Data Analysis Platform provides end-to-end support for regulatory submissions, compliance, and documentation.

+ Read More
Formulation

Dossier and Product Registration Support

We offer comprehensive dossier preparation and product registration support, ensuring smooth regulatory approvals across multiple regions.

+ Read More
Formulation

Market Analysis and Commercial Assessment

Our Market Analysis and Commercial Assessment services provide in-depth insights into industry trends, competitive landscapes, and market potential.

+ Read More
Formulation

R&D quality assurance

R&D Quality Assurance Trust our expertise to safeguard the integrity, compliance, and safety of your innovations with a touch of quality.

+ Read More
Formulation

Quality Compliance and Operational Efficiency

Committed to excellence, we ensure rigorous quality compliance and thorough audits, safeguarding industry standards and patient safety with precision, integrity, and unwavering dedication.

+ Read More
Pharma CDMO

Diverse Formulation Tech Solutions: Conventional, Complex Generics & OTC Drug products

Our expertise across various dosage forms and therapeutic areas ensures cutting-edge, QbD-driven solutions tailored to meet diverse pharmaceutical needs.

Ophthalmic : Multidose and Unit Dose Preserved and Preservative Free, Solutions, Suspensions, In Situ Gel Forming and Semisolids.

Nasal : Multidose and Unit Dose Preserved and Preservative Free Solutions, Suspensions Dry Powder, In Situ Gelling and Gels

Inhalation : Pressurized Metered Dose Nasals, Nebulized and Pressurized Metered Dose Inhalers, and Dry Powder Inhalers (DPI)

Complex Injectables : Multidose and Unit Dose Pre-Filled Syringes, LyphoIlised Powders, Solutions, Suspension, Microspheres, In Situ Gelling and Gels for Depot Injections.

Oral Liquids : Multidose, Unit Dose, Palatable (Taste Making), Immediate and Extended Release, Dry Powders for Solutions/Suspensions, Liquid Solutions, Liquid Suspensions, Emulsions, Nano-Emulsions

Topicals : Semisolids, Paste, medicated patches, and Liquid Formulations

Oral Solids : Immediate and Extended-Release Tablets, Soft & Hard Gelatin Capsules with expertise in Multi-particulates, and Solubility Enhancement thru Amorphous Solid Dispersion and Lipid -Based Formulation Development, Oral films Logenges, and gummies.

Analytical Development

01.

Method Development & Validation

  • Physical and chemical properties of API
  • Assay/ Potency
  • Degradation/Organic impurities
  • Elemental impurities
  • Dissolution / Release
  • Microbial limit and sterility

02.

Stability Test

  • Stability study protocol refers to ICH
  • Degradation experiment
  • Stability research of registration batch
  • Stability test of placebo and control drug
  • GMP quality system compliance

03.

Test & Release

  • Release test
  • R&D support
  • In vitro release study based on PK/PD
  • Qualitative analysis of degradation impurities
  • Reverse analysis of RLD

04.

Support for Filling

  • CMC data preparation for ANDA/ IND/ phase Ⅰ
  • CMC support of new drug clinical communication meeting
  • Submission of CTD application data
  • Reply to drug administration feedback